NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
XBiotech Inc (NASDAQ: XBIT)
XBIT Technical Analysis
4
As on 9th Jun 2023 XBIT STOCK Price closed @ 5.45 and we RECOMMEND Sell for LONG-TERM with Stoploss of 6.77 & Strong Sell for SHORT-TERM with Stoploss of 10.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XBITSTOCK Price
Open | 5.57 | Change | Price | % |
High | 5.63 | 1 Day | -0.05 | -0.91 |
Low | 5.30 | 1 Week | -0.02 | -0.37 |
Close | 5.45 | 1 Month | 2.13 | 64.16 |
Volume | 54700 | 1 Year | -6.09 | -52.77 |
52 Week High 11.71 | 52 Week Low 3.03 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
XBIT Daily Charts |
XBIT Intraday Charts |
Whats New @ Bazaartrend |
XBIT Free Analysis |
|
XBIT Important Levels Intraday
RESISTANCE | 6.09 |
RESISTANCE | 5.88 |
RESISTANCE | 5.76 |
RESISTANCE | 5.63 |
SUPPORT | 5.27 |
SUPPORT | 5.14 |
SUPPORT | 5.02 |
SUPPORT | 4.81 |
XBIT Forecast April 2024
4th UP Forecast | 10.5 |
3rd UP Forecast | 8.88 |
2nd UP Forecast | 7.88 |
1st UP Forecast | 6.88 |
1st DOWN Forecast | 4.02 |
2nd DOWN Forecast | 3.02 |
3rd DOWN Forecast | 2.02 |
4th DOWN Forecast | 0.4 |
XBIT Weekly Forecast
4th UP Forecast | 6.90 |
3rd UP Forecast | 6.43 |
2nd UP Forecast | 6.15 |
1st UP Forecast | 5.86 |
1st DOWN Forecast | 5.04 |
2nd DOWN Forecast | 4.75 |
3rd DOWN Forecast | 4.47 |
4th DOWN Forecast | 4.00 |
XBIT Forecast2024
4th UP Forecast | 22.6 |
3rd UP Forecast | 17.1 |
2nd UP Forecast | 13.7 |
1st UP Forecast | 10.3 |
1st DOWN Forecast | 0.6 |
2nd DOWN Forecast | -2.8 |
3rd DOWN Forecast | -6.2 |
4th DOWN Forecast | -11.7 |
XBiotech Inc ( NASDAQ USA Symbol : XBIT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XBIT Other Details
Segment | EQ | |
Market Capital | 435623392.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
XBIT Address
XBIT Latest News
XBIT Business Profile
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and True Human COVID-19 therapy for treating the COVID-19 mutant virus. In addition, the company provides clinical trial contract research operations to conduct two large, double-blind placebo-controlled Phase II clinical studies. The company was incorporated in 2005 and is headquartered in Austin, Texas. Address: 5217 Winnebago Lane, Austin, TX, United States, 78744
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service